Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy PDS Biotechnology stock
Learn how to easily invest in PDS Biotechnology stock.
PDS Biotechnology Corp is a biotechnology business based in the US. PDS Biotechnology shares (PDSB) are listed on the NASDAQ and all prices are listed in US Dollars. PDS Biotechnology employs 22 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in PDS Biotechnology
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – PDSB – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
PDS Biotechnology stock price (NASDAQ: PDSB)Use our graph to track the performance of PDSB stocks over time.
PDS Biotechnology shares at a glance
|Latest market close||$3.19|
|52-week range||$2.91 - $15.82|
|50-day moving average||$4.36|
|200-day moving average||$5.39|
|Wall St. target price||$19.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.84|
Buy PDS Biotechnology shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy PDS Biotechnology stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
PDS Biotechnology price performance over time
|1 week (2022-09-21)||-3.33%|
|1 month (2022-08-29)||-26.83%|
|3 months (2022-06-29)||-15.61%|
|6 months (2022-03-29)||-49.76%|
|1 year (2021-09-29)||-78.52%|
|2 years (2020-09-29)||36.91%|
|3 years (2019-09-27)||3.4843|
|5 years (2017-09-28)||10.72|
PDS Biotechnology financials
|Gross profit TTM||$0|
|Return on assets TTM||-27.04%|
|Return on equity TTM||-44.32%|
|Market capitalisation||$85.1 million|
TTM: trailing 12 months
PDS Biotechnology share dividends
We're not expecting PDS Biotechnology to pay a dividend over the next 12 months.
Have PDS Biotechnology's shares ever split?
PDS Biotechnology's shares were split on a 1:20 basis on 17 March 2019. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your PDS Biotechnology shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for PDS Biotechnology shares which in turn could have impacted PDS Biotechnology's share price.
PDS Biotechnology share price volatility
Over the last 12 months, PDS Biotechnology's shares have ranged in value from as little as $2.91 up to $15.82. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PDS Biotechnology's is 1.7667. This would suggest that PDS Biotechnology's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
PDS Biotechnology overview
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related protein 2 for the treatment of melanoma. In addition, it is developing PDS0201 for treating tuberculosis; PDS0202, an influenza vaccine candidate; and PDS0203, a vaccine for the prevention of COVID-19. The company has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U. S. Department of Health and Human Services, and MSD International GmbH.
PDS Biotechnology in the news
PDS Biotech Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PDS Biotech to Participate at Cantor Fitzgerald’s Oncology & HemOnc Conference
PDS Biotech and National Cancer Institute Identify Optimal Patient Group for Advancing PDS0101-Based Triple Combination Program Targeting Advanced HPV-Positive Cancers
Frequently asked questionsWhat percentage of PDS Biotechnology is owned by insiders or institutions?
Currently 14.259% of PDS Biotechnology shares are held by insiders and 19.542% by institutions. How many people work for PDS Biotechnology?
Latest data suggests 22 work at PDS Biotechnology. When does the fiscal year end for PDS Biotechnology?
PDS Biotechnology's fiscal year ends in December. Where is PDS Biotechnology based?
PDS Biotechnology's address is: 25B Vreeland Road, Florham Park, NJ, United States, 07932 What is PDS Biotechnology's ISIN number?
PDS Biotechnology's international securities identification number is: US70465T1079 What is PDS Biotechnology's CUSIP number?
PDS Biotechnology's Committee on Uniform Securities Identification Procedures number is: 279870109
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert